Table 1. Distribution of study subjects and liver function tests.
BA | NC | P | |
Age (days)* | 71.50±17.52 | 65.91±12.33 | 0.25 |
Male/Female | 12/8 | 7/5 | 0.31 |
Diagnosis type | III1 | N/A | |
TB (μmol/L) | 198.1±105.45 | 161.33±52.79 | 0.61 |
DB (μmol/L) | 144.52±74.38 | 121.92±37.67 | 0.47 |
DB/TB | 0.74±0.59 | 0.76±0.51 | 0.09 |
AST (IU/L) | 262.5±237.50 | 230.9±208.43 | 0.18 |
ALT (IU/L) | 121.1±113.75 | 142.3±147.97 | 0.45 |
γ-GGT | 800.88±727 | 253.0±215.64 | 0.01 |
1. Type III biliary atresia refers to the discontinuity of both right and left hepatic ducts to the level of the porta hepatis. Unfortunately, type III BA is common, accounting for >90% of cases. *at liver biopsy sample day.
BA: biliary atresia; NC: non-BA neonatal cholestasis infants.
ALT: Alanine transaminase; AST: Aspartate transaminase; DB: Direct bilirubin; TB: Total bilirubin; γ-GGT: Gamma glutamyl transpeptidase.